Literature DB >> 27660109

Choosing the right protein A affinity chromatography media can remove aggregates efficiently.

Tomokazu Yada1, Koichi Nonaka1, Masayuki Yabuta1, Noriko Yoshimoto2, Shuichi Yamamoto2.   

Abstract

Protein A chromatography (PAC) is commonly used as an efficient capture step in monoclonal antibody (mAb) separation processes. Usually dynamic binding capacity is used for choosing the right PAC. However, if aggregates can be efficiently removed during elution, it can make the following polishing steps easier. In this study a method for choosing the right PAC media in terms of mAb aggregate removal is proposed. Linear pH gradient elution experiments of two different mAbs on various PAC columns are carried out, where the elution behavior of aggregates as well as the monomer is measured. Aggregates of one mAb are more strongly retained compared with the mAb monomer. Another mAb showed different elution behavior, where the aggregates are eluted as both the weakly and strongly retained peaks. In order to remove the two types of aggregates by stepwise elution two protocols are tested. The first protocol A consisted of the sample loading, the wash with the equilibration buffer and the low pH elution. The wash stage of the second protocol B included the wash with 1.0 M arginine. No detectable peaks are observed during the wash stage of protocol A whereas significant peaks are monitored during the arginine wash of protocol B. One of the PAC columns showed a smaller peak during the arginine wash. In addition, both aggregate removal and monomer yield are higher with protocol B compared with the other PAC columns. This method is found to be useful for choosing the right PAC column.
Copyright © 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Arginine; Monoclonal antibody; Protein A chromatography; Protein aggregates; pH gradient elution

Mesh:

Substances:

Year:  2016        PMID: 27660109     DOI: 10.1002/biot.201600427

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  3 in total

1.  Expression and purification optimization of an N-terminal Pfs230 transmission-blocking vaccine candidate.

Authors:  Shwu-Maan Lee; Jordan Plieskatt; Seetha Krishnan; Monika Raina; Rakeshkumar Harishchandra; C Richter King
Journal:  Protein Expr Purif       Date:  2019-04-10       Impact factor: 1.650

2.  An Integrated Approach to Aggregate Control for Therapeutic Bispecific Antibodies Using an Improved Three Column Mab Platform-Like Purification Process.

Authors:  Cassia Andrade; Lindsay Arnold; Dana Motabar; Matthew Aspelund; Alison Tang; Alan Hunter; Wai Keen Chung
Journal:  Biotechnol Prog       Date:  2018-10-17

Review 3.  Protein aggregation and immunogenicity of biotherapeutics.

Authors:  Ngoc B Pham; Wilson S Meng
Journal:  Int J Pharm       Date:  2020-06-09       Impact factor: 5.875

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.